Insights

Gathering insights about Cartesi…

Similar companies to Cartesi

Cartesi Tech Stack

Cartesi uses 8 technology products and services including Amazon CloudFront, Open Graph, Cloudflare, and more. Explore Cartesi's tech stack below.

Amazon CloudFront
Content Delivery Network
Open Graph
Content Management System
Cloudflare
Content Management System
Webpack
Development
Swiper
Javascript Libraries
shadcn/ui
UI Frameworks
Radix UI
UI Frameworks
Facebook
Widgets

Media & News

Cartesian Therapeutics Announces New Employment Inducement Grant
FREDERICK, Md., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of an inducement award to one new employee. On October 2, 2025, the Company issued to this employee an option to purchase an aggregate of 9,700 shares of the Company's common stock with an exercise price of $10.34, the closing trading price of the Company's common stock on the Nasdaq Global Market on the date of grant. The option was granted pursuant to the Company's Amended and Restated 2018 Employment Inducement Incentive Award Plan and was approved by the Company's board of directors. The option vests as to 25% on October 2, 2026, and then in three equal annual installments thereafter such that the option will be fully vested on October 2, 2029. The option has a ten-year term. The option was granted under Rule 5635(c)(4) of the Nasdaq Listing Rules as an inducement material to the employee's entry into employment with the Company.
Oct 03, 2025 | www.globenewswire.com
Cartesian Therapeutics, Inc. (RNAC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Cartesian Therapeutics, Inc. (NASDAQ:RNAC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:05 PM EDT Company Participants Carsten Brunn - President, CEO & Director Milos Miljkovic - Chief Medical Officer Conference Call Participants Ross Cohen - Morgan Stanley Presentation Ross Cohen So really quickly on disclosures. So for important disclosures, please see the Morgan Stanley research disclosure website.
Sep 09, 2025 | seekingalpha.com
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
FREDERICK, Md., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in September:
Aug 28, 2025 | www.globenewswire.com
Cartesian (RNAC) Q2 Revenue Drops 99%
Cartesian (RNAC) Q2 Revenue Drops 99%
Aug 07, 2025 | www.fool.com
Cartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last?
Cartesian Therapeutics, Inc. (RNAC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Jul 24, 2025 | www.zacks.com
Cartesian Therapeutics Announces New Employment Inducement Grants
FREDERICK, Md., June 03, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of inducement awards to three new employees. On June 2, 2025, the Company issued to these employees options to purchase an aggregate of 26,350 shares of the Company's common stock with an exercise price of $9.98, the closing trading price of the Company's common stock on the Nasdaq Global Market on the date of grant. The options were granted pursuant to the Company's Amended and Restated 2018 Employment Inducement Incentive Award Plan and were approved by the Company's board of directors. The options vest as to 25% on June 2, 2026, and then in three equal annual installments thereafter such that the options will be fully vested on June 2, 2029. The options have a ten-year term. The options were granted under Rule 5635(c)(4) of the Nasdaq Listing Rules as an inducement material to the employees' entry into employment with the Company.
Jun 03, 2025 | www.globenewswire.com
Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
FREDERICK, Md., May 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that the first participant has been enrolled in its Phase 3 AURORA trial of Descartes-08 in patients with myasthenia gravis (MG).
May 30, 2025 | www.globenewswire.com

Cartesi's Email Address Formats

Cartesi uses at least 1 format(s):

Cartesi Email Formats	Example	Percentage
First.Last@cartesi.io	John.Doe@cartesi.io	42%
First@cartesi.io	John@cartesi.io	11%
Last@cartesi.io	Doe@cartesi.io	5%
First.Last@cartesi.io	John.Doe@cartesi.io	42%

Frequently Asked Questions

Where is Cartesi's headquarters located?

Cartesi's main headquarters is located at Singapore, Central Region Singapore. The company has employees across 6 continents, including South AmericaAsiaEurope.

What is Cartesi's stock symbol?

Cartesi is a publicly traded company; the company's stock symbol is CRTN.

What is Cartesi's official website and social media links?

Cartesi's official website is cartesi.io and has social profiles on LinkedIn.

What is Cartesi's NAICS code?

Cartesi's NAICS code is 5112 - Software Publishers.

How many employees does Cartesi have currently?

As of February 2026, Cartesi has approximately 43 employees across 6 continents, including South AmericaAsiaEurope. Key team members include Head Of Engineering: D. T.Director User Experience Design (cartesi Grantee): A. L.Software Project Manager: C. S.. Explore Cartesi's employee directory with LeadIQ.

What industry does Cartesi belong to?

Cartesi operates in the Software Development industry.

What technology does Cartesi use?

Cartesi's tech stack includes Amazon CloudFrontOpen GraphCloudflareWebpackSwipershadcn/uiRadix UIFacebook.

What is Cartesi's email format?

Cartesi's email format typically follows the pattern of First.Last@cartesi.io. Find more Cartesi email formats with LeadIQ.

Cartesi

Q: What is Cartesi's official website and social media links?

Cartesi's official website is cartesi.io. Cartesi has social profiles on LinkedIn.

Q: How many employees does Cartesi have currently?

Cartesi has approximately 43 employees.

Q: What technology does Cartesi use?

Cartesi's tech stack includes Amazon S3, Facebook Pixel, Google Ads Conversion Tracking, HTTP/3, Twitter Ads.

Software DevelopmentCentral Region, Singapore11-50 Employees

Cartesi enables developers to build appchain rollups with any code, while benefiting from the security of Ethereum. It bridges the gap between traditional software and blockchain by bringing decades of mature operating systems, programming languages, libraries, and tools to decentralized applications.

To learn more about Cartesi, visit https://cartesi.io/